Trials / Completed
CompletedNCT04420091
Hydrolyzed Fish Cartilage Effect on Knee Joint Functionality and Discomfort in Adult Population
Effect of Cartidyss-based Dietary Supplement on Knee Joint Functionality and Discomfort in Adult Population
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 32 (actual)
- Sponsor
- Abyss Ingredients · Industry
- Sex
- All
- Age
- 40 Years – 80 Years
- Healthy volunteers
- Accepted
Summary
This study is an exploratory, non-comparative, multi-centric trial in 30 free-living healthy male and female subjects with moderate knee joint discomfort and loss of functionality. The objective of this trial is to determine whether oral administration of Cartidyss, a concentrated fish cartilage extract, can contribute to the improvement of knee joint functionality and discomfort in adult population
Detailed description
30 patients will be enrolled during a 4-month period in 3 investigational sites and each patient will undergo 3 visits (V0: Inclusion visit at baseline, V1: Follow-Up Visit after 1 month ± 3 day and V2: End Visit after 3 months ± 5 days). The primary objective of this trial is to determine whether oral administration of Cartidyss, a concentrated fish cartilage extract, can contribute to the improvement of knee joint functionality and discomfort in adult population, using a specific self-administered questionnaire. The secondary objectives of the study are to evaluate the effect of Cartidyss on knee function and pain at rest and while walking, with patient global assessment and quality of life at each time point. The tolerance, compliance, satisfaction, rate of responder to the supplementation and pain killer's consumption would be also evaluated as secondary endpoints.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Cartidyss | Oral intake of two tablets of Cartidyss 500 mg, once daily in the morning, preferably during a meal, with water, during 3 months |
Timeline
- Start date
- 2020-06-11
- Primary completion
- 2020-12-17
- Completion
- 2020-12-17
- First posted
- 2020-06-09
- Last updated
- 2021-01-06
Locations
2 sites across 1 country: Belgium
Source: ClinicalTrials.gov record NCT04420091. Inclusion in this directory is not an endorsement.